Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced Rectal Cancer × Diathermy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hyperthermia 16 Sarcoma 5 Prostatic Neoplasms 5 Uterine Cervical Neoplasms 4 Rectal Neoplasms 4 Neoplasm Metastasis 4 Colonic Neoplasms 4 Breast Neoplasms 4 Urinary Bladder Neoplasms 3 Ovarian Neoplasms 3 Neoplasms 3 Melanoma 3 Head and Neck Neoplasms 3 Carcinoma, Hepatocellular 3 Lung Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Salivary Gland Adenoma, Pleomorphic 1 Prehypertension 1 Prediabetic State 1 Polycystic Ovary Syndrome 1 Peritoneal Neoplasms 1 Pelvic Pain 1 Pancreatic Neoplasms 1 Obesity 1 Neoplasms, Radiation-Induced 1 Metabolic Syndrome 1

Interventions

Capecitabine 17 Oxaliplatin 9 spartalizumab 7 Irinotecan 7 tislelizumab 4 Neoadjuvant Therapy 4 Fluorouracil 4 toripalimab 3 Radiation 3 sintilimab 2 Radiotherapy 2 Leucovorin 2 Immune Checkpoint Inhibitors 2 Celecoxib 2 veliparib 1 peposertib 1 irinotecan sucrosofate 1 camrelizumab 1 XELOX 1 Thymalfasin 1 Radiotherapy, Intensity-Modulated 1 Injections 1 HMPL-013 1 Folfox protocol 1 Diathermy 1 Combined Modality Therapy 1 Chemoradiotherapy 1 Amifostine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02290574 2019-11-01

NEOTREAT

Samsung Medical Center

Phase NA Terminated

14 enrolled 7 charts

Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡